Le marché des antipaludéens, entre régulation et défaillance

Fabienne Orsi and Jean-Benoit Zimmermann

Mondes en développement, 2015, vol. n° 170, issue 2, 21-40

Abstract: Faced with the rise of resistance to monotherapies, the artemisinine-combination therapies (ACTs) have become the early 2000s, the golden standard in the fight against plasmodium falciparum malaria. Because of the need to substitute these therapies to older drugs and given the vastly more expensive ACTs, World Health Organization has established itself in global prescriber, enacting, on the one hand, health policy recommendations towards the endemic countries and organizing, on the other, a global supply chain. This article analyzes the disconnection that results from this model of governance, between the national and global levels and the consequences on the health status of malarious countries.

Keywords: malaria; artemisinin; ACT; global governance; health policies; production; financing; price; intellectual property (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=MED_170_0021 (application/pdf)
http://www.cairn.info/revue-mondes-en-developpement-2015-2-page-21.htm (text/html)
free

Related works:
Working Paper: Le marché des antipaludéens: entre régulation et défaillance (2015)
Working Paper: Le Marché des Antipaludéens: Entre Régulation et Défaillance (2014)
Working Paper: Le Marché des Antipaludéens: Entre Régulation et Défaillance (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:meddbu:med_170_0021

Access Statistics for this article

More articles in Mondes en développement from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().